AI Delivers Real Results, Demands Real Security and Compliance Now

The long-predicted impact of AI is here, moving from vendor promises to concrete, measurable outcomes. This shift, however, brings an urgent need for proactive security and compliance, not just innovation. I have seen enough tech cycles to know that those who wait for perfect clarity are often left behind with significant problems. Signal: Insilico Medicine's AI-driven candidate, Rentosertib, received IND clearance for a direct-to-lung clinical study. This is the world's first AI-driven candidate to enter a direct-to-lung clinical study. This changes the timeline for competitive drug discovery for European CROs and small biotech. Your current pipeline could face faster, AI-accelerated competition, making EU AI Act enforcement in 2026 critical. Signal: Konexo Legal, founded by ex-Mishcon partners, appointed legal AI expert Dana Denis-Smith as a partner. This isn't about buying another tool; it is about talent. Smaller European firms must consider how to bring this expertise in-house, not just outsource it, especially with the EU AI Act countdown. Signal: EPC Group now offers a service to review Copilot and Microsoft 365 tenant security. The company found 80% of existing M365 tenants are misconfigured, posing security risks. If 80% of tenants are misconfigured, your client data is exposed, and your firm is non-compliant with GDPR, let alone the EU AI Act. Using Copilot without proper security is a professional liability. These developments underscore that AI's benefits are intertwined with critical security and regulatory responsibilities that require immediate attention.